Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IGFBP4 |
| Upstream (Parents) |
|---|
| (<<) CBS → IGFBP4 |
| (<<) CTSF → IGFBP4 |
| (<<) HDAC2 → IGFBP4 |
| (<<) IGFBP3 → IGFBP4 |
| (<<) IL1R1 → IGFBP4 |
| (<<) NGFR → IGFBP4 |
| (<<) NNMT → IGFBP4 |
| (<<) NR3C1 → IGFBP4 |
| (<<) ORM1 → IGFBP4 |
| (<<) PPAP2A → IGFBP4 |
| (<<) ST3GAL6 → IGFBP4 |
| Downstream (Children) |
|---|
| IGFBP4 → ARSD (>>) |
| IGFBP4 → BZW2 (>>) |
| IGFBP4 → CASP6 (>>) |
| IGFBP4 → CDK8 (>>) |
| IGFBP4 → CDR2 (>>) |
| IGFBP4 → CLDN5 (>>) |
| IGFBP4 → DAZAP2 (>>) |
| IGFBP4 → DDX18 (>>) |
| IGFBP4 → DLAT (>>) |
| IGFBP4 → E2F3 (>>) |
| IGFBP4 → ENO1 (>>) |
| IGFBP4 → FZD4 (>>) |
| IGFBP4 → HSP90AB1 (>>) |
| IGFBP4 → IFITM3 (>>) |
| IGFBP4 → KLF11 (>>) |
| IGFBP4 → LAMB2 (>>) |
| IGFBP4 → MYC (>>) |
| IGFBP4 → NFKBIA (>>) |
| IGFBP4 → PALM (>>) |
| IGFBP4 → PDE2A (>>) |
| IGFBP4 → PIK3CB (>>) |
| IGFBP4 → PNO1 (>>) |
| IGFBP4 → RAF1 (>>) |
| IGFBP4 → RDX (>>) |
| IGFBP4 → RHOB (>>) |
| IGFBP4 → RHOD (>>) |
| IGFBP4 → SEH1L (>>) |
| IGFBP4 → TARS (>>) |
| IGFBP4 → TK2 (>>) |
| IGFBP4 → TNFRSF1A (>>) |
| IGFBP4 → TYK2 (>>) |
| IGFBP4 → VCP (>>) |
| IGFBP4 → YWHAZ (>>) |
